Novartis’ $5 Billion Bond Offering


Mayer Brown advised Novartis AG and Novartis Capital Corporation in connection with a $5 billion four-tranche SEC-registered bond offering.

Citigroup Global Markets Inc., HSBC Securities (USA) Inc., Morgan Stanley & Co. LLC and MUFG Securities Americas Inc., Barclays Capital Inc., Deutsche Bank Securities Inc. and Mizuho Securities USA LLC acted as joint book-running managers.

Novartis is a leading global medicines company that uses innovative science and digital technologies to create transformative treatments in areas of great medical need.

The Mayer Brown team was led by Banking & Finance partner Bernd Bohr (Picture; London), supported by Banking & Finance associate Whitney Joseph (London), Tax Transactions & Consulting partner Jared Goldberger and associates Juan Lopez Valek and Brennan Young (all New York) and Financial Services Regulatory & Enforcement partner Jeffrey P. Taft (Washington DC).

Involved fees earner: Bernd Bohr – Mayer Brown; Jared Goldberger – Mayer Brown; Whitney Joseph – Mayer Brown; Juan Lopez Valek – Mayer Brown; Jeffrey Taft – Mayer Brown; Brennan Young – Mayer Brown;

Law Firms: Mayer Brown;

Clients: Novartis AG;